Latest News

CRA International stock triggered by recent performance CRA International (CRAI) has caught investor attention after a recent run that includes a 14.49% move over the past month and a 19.63% gain over the past 3 months, prompting a closer look at its fundamentals. See our latest analysis for CRA International. Looking beyond the recent run, CRA International’s 1-year total shareholder return of 17.86% and 5-year total shareholder return of 283.90% point to momentum that has built over time...

Edwards Lifesciences (EW) is back in focus after a series of upbeat analyst updates and fresh FDA approval for its SAPIEN M3 mitral valve replacement system. This development is one that investors are watching closely. See our latest analysis for Edwards Lifesciences. At a share price of $84.83, Edwards Lifesciences has seen short term share price returns move only slightly. Its 12.82% 90 day share price return and 14.40% 1 year total shareholder return indicate that momentum has been...

Why Scotts Miracle-Gro is on investors’ radar today Scotts Miracle-Gro (SMG) has attracted fresh attention after recent share price moves, with the stock closing at $58.92 and showing mixed performance over the past month and past 3 months. See our latest analysis for Scotts Miracle-Gro. Recent trading has been choppy, with a 1 day share price return of a 3.54% decline following a 30 day share price return of 12.49%. The 1 year total shareholder return of an 8.42% decline contrasts with a 3...

In December 2025, Weebit Nano Limited announced it had licensed its ReRAM non-volatile memory technology to Texas Instruments, enabling integration into TI's advanced process nodes for embedded processing, with the agreement covering IP licensing, technology transfer, and qualification for high-temperature, automotive-grade use. This deal, alongside Weebit Nano’s fiscal 2026 minimum revenue guidance of A$10,000,000, underscores growing commercial traction for its low-power memory technology...

Topaz Energy Corp.'s ( TSE:TPZ ) price-to-earnings (or "P/E") ratio of 71.5x might make it look like a strong sell...

As the Australian market navigates a period of subdued activity, with materials experiencing a notable sell-off despite rising iron ore futures, investors are keenly observing economic signals from China and their impact on local sectors. In this environment, dividend stocks can offer stability and income potential, making them an attractive option for those looking to balance risk while capitalizing on consistent returns.

As the Australian market navigates through a period of mixed performance, with materials experiencing a sell-off despite rising iron ore futures and healthcare leading gains, investors are keenly observing potential opportunities. In this environment, identifying stocks that may be trading below their fair value can offer intriguing possibilities for those looking to capitalize on market inefficiencies.

As the Australian market navigates a landscape marked by fluctuating commodity prices and ongoing economic stimuli from China, investors are keenly observing sector movements such as the recent materials sell-off and healthcare gains. In this context, penny stocks—often representing smaller or newer companies—continue to capture interest for their potential to deliver notable returns despite their niche status. While the term may seem outdated, these stocks can still offer promising...

San-A Co., Ltd. (TSE:2659) has reported Q3 2026 revenue of ¥55.3b and basic EPS of ¥35.62, with trailing twelve month EPS at ¥184.34 and net income at ¥11.4b framing the latest quarter in a wider profit context. The company has seen quarterly revenue move between ¥54.4b and ¥67.9b over the last five reported periods, while EPS has ranged from about ¥35.6 to ¥53.74 as earnings tracked this revenue base. For investors, the current set of numbers points to a business where profit margins and...

Wolfe Research recently upgraded Vertex Pharmaceuticals from “Peer Perform” to “Outperform,” citing a shifting outlook for its potential IgA nephropathy treatment, including the planned use of a priority review voucher to accelerate regulatory timelines. The upgrade highlights how competitive pricing moves in kidney disease and rising confidence in early‑2026 data for povetacicept could influence Vertex’s pipeline mix beyond cystic fibrosis. We’ll now explore how growing optimism around...

GE Vernova recently marked a technology milestone as its 9HA gas turbines entered commercial operation at Vietnam’s first LNG-powered 1.6 GW Nhon Trach 3&4 power plant, supporting grid reliability and cleaner power generation. This deployment, combined with a decline in short interest and growing international adoption of GE Vernova’s hardware and software, highlights building confidence in its role in the global energy transition. We’ll now examine how the Vietnam LNG power plant launch...

Why Trinity Industries is back on investors’ radar Trinity Industries (TRN) is drawing fresh attention after it overhauled railcar investment partnerships with Napier Park, raised 2025 earnings guidance, and flagged a sizeable non-cash gain tied to its Triumph Holdings exit. See our latest analysis for Trinity Industries. The guidance upgrade and restructuring news came after a mixed period, with a 7.01% year to date share price return but a 13.67% decline in 1 year total shareholder return...

Establishment Labs recently submitted its Motiva breast implants to the FDA for an expanded label covering primary and revision breast reconstruction, a major step for its reconstructive portfolio. An important follow-on milestone came when management appeared at the 44th Annual J.P. Morgan Healthcare Conference, giving investors fresh insight into how this potential label expansion could influence product positioning and future indications. We’ll now examine how the FDA submission for...

Why Thacker Pass keeps Lithium Americas in focus Recent attention on Lithium Americas (TSX:LAC) is tied to ongoing developments at its Thacker Pass lithium project, where regulatory milestones, financing talks, and EV market relevance are all in focus for investors. See our latest analysis for Lithium Americas. At a share price of CA$7.77, Lithium Americas has seen short term momentum pick up, with a 7 day share price return of 30.15%. In contrast, the 90 day share price return shows a...

Recent commentary around Q2 Holdings (QTWO) has focused on slower annual recurring revenue growth, an expected deceleration in sales, and a gross margin level that trails peers, raising fresh questions for investors about the stock’s risk and reward. See our latest analysis for Q2 Holdings. Against that backdrop, Q2 Holdings’ share price of $71.50 sits after a 12.9% 90 day share price return and a 1 year total shareholder return decline of 28.4%. This suggests recent momentum is building from...

MasTec stock at a glance MasTec (MTZ) has been drawing fresh attention after recent share price moves, with the stock last closing at US$235.75. That has investors revisiting its infrastructure-focused business and current valuation. See our latest analysis for MasTec. Recent trading has been choppy, with a 1-day share price return of a 0.25% decline, a 7-day share price return of 8.46%, and a 90-day gain of 12.21%. Over the longer stretch, total shareholder returns of 60.84% over 1 year and...

Raymond James’ upgrade of Stryker (SYK) to “Outperform” has put the stock back in focus after the firm highlighted five years of double digit organic revenue growth and a stronger financial outlook. See our latest analysis for Stryker. The Raymond James upgrade appears to have acted as a fresh catalyst after a softer 90 day share price return of a 0.66% decline. The recent 7 day share price return of 4.63% and a 1 year total shareholder return of 1.94% suggest momentum is picking up from a...

Recently, OPENLANE, Inc. (NYSE: OPLN) announced an in-person Investor Day held on March 3, 2026, in Fort Lauderdale and expanded its Canadian receivables program limit to C$500 million with support from a lender group led by Royal Bank of Canada, alongside a ticker change from "KAR" to "OPLN" in December 2025. Together, these updates highlight OPENLANE’s emphasis on funding capacity, technology and operating plans, and clearer branding, giving investors more detail on how management is...

If you are looking at Alexandria Real Estate Equities and wondering whether the current share price still reflects its underlying worth, you are not alone. The stock trades at US$52.18, with returns of 6.6% over the last week and 16.0% over the last month, set against a 6.6% return year to date and a 43.0% decline over the past year, as well as 60.5% and 62.0% declines over the last 3 and 5 years. Recent moves in the share price have come against a backdrop of ongoing attention on listed...

What recent performance might be telling you Takeda Pharmaceutical (TSE:4502) has caught investor attention after a recent stretch of positive returns, with the share price up over the past week, month, past 3 months and year to date. That shorter term strength sits alongside a 1 year total return figure and multi year total return track record. This has prompted some investors to compare those gains with Takeda’s reported revenue, net income and current valuation metrics. See our latest...

Deere recently saw its shares lag the broader market after past trading sessions, as investors reacted to expectations of a sharp year-over-year earnings-per-share decline despite revenue growth ahead of its upcoming report. This tension between anticipated revenue expansion and weaker profitability has sharpened focus on how efficiently Deere is converting rising sales into bottom-line results. Against this backdrop of expected earnings pressure despite higher revenue, we’ll now examine...

If you are wondering whether Rezolve AI's share price lines up with its underlying worth, this article will walk through what the current numbers might be telling you. The stock last closed at US$3.25, with returns of 26.5% over 7 days, 18.2% over 30 days, 13.2% year to date, 9.4% over 1 year and a 68.0% decline over 3 years, which gives a mixed picture of recent and longer term sentiment. Recent market attention on Rezolve AI has been shaped by ongoing coverage of artificial intelligence...

In early January 2026, Wells Fargo upgraded Werner Enterprises to “Equal Weight,” citing an expected truckload sector recovery supported by supply adjustments and rail M&A activity, while emphasizing Werner’s disciplined operations and asset positioning. The upgrade highlights how Werner’s focus on cost control, network optimization, and steady contract wins could help stabilize earnings even if spot freight rates remain subdued. Next, we’ll examine how Wells Fargo’s upgrade and its focus on...

TORM plc recently confirmed that Oaktree Capital Management’s ownership has fallen below the one-third threshold, extinguishing the B-Director role, prompting Deputy Chairman and Senior Independent Director David Weinstein to leave the Board on January 6, 2026, while staying on as Special Advisor. Alongside this, TORM is redeeming and cancelling its B- and C-shares, simplifying its capital structure and consolidating voting power into 101,332,707 A-shares and a single remaining B-share until...